Cleveland Clinic Study Will Measure NSAID Safety In Heart Disease Patients
This article was originally published in The Tan Sheet
Executive Summary
The cardiovascular safety of ibuprofen, naproxen and celecoxib (Pfizer's Celebrex) will be compared in a worldwide clinical trial involving 20,000 patients, the Cleveland Clinic announced Dec. 13